This is a preview of subscription content, log in via an institution to check access.
References
Stripecke R et al. Immune response to green fluorescent protein: implications for gene therapy Gene Therapy 1999 6: 1305–1312
Gambotto A et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope Gene Therapy 2000 7: 2036–2040
Rosenzweig M et al. Induction of cytoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells Blood 2001 97: 1951–1959
Miller AD, Rosen GJ . Improved retroviral vectors for gene transfer and expression BioTechniques 1989 7: 980–990
Banerjee PT et al. A polycistronic retrovirus vector for expression of swine MHC class II DRα/β heterodimers Xenotransplantation 1997 4: 161–173
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Denaro, M., Oldmixon, B., Patience, C. et al. EGFP-transduced EL-4 cells from tumors in C57BL/6 mice. Gene Ther 8, 1814–1815 (2001). https://doi.org/10.1038/sj.gt.3301601
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301601
- Springer Nature Limited
This article is cited by
-
Options for tracking GFP-Labeled transplanted myoblasts using in vivofluorescence imaging: implications for tracking stem cell fate
BMC Biotechnology (2014)
-
Identification of the immunodominant CTL epitope of EGFP in C57BL/6 mice
Gene Therapy (2008)
-
Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice
Oncogene (2006)
-
Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity
Cancer Immunology, Immunotherapy (2006)
-
The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice
Gene Therapy (2001)